Bios Health Group Unveils Bios Innovation Circle
April 9, 2024 – Biotechnology, Pharmaceutical – Bios Health Group, Bios Innovation Circle, investment partner, life sciences
Ground-breaking venture studio and strategic hub empowers members with comprehensive arsenal of benefits to dominate the life sciences arena
9 April 2024 — Georgia, US — Bios Health Group, a leading strategic and investment partner for life sciences companies and investors, has today formally launched the Bios Innovation Circle – a ground-breaking venture studio and strategic hub, designed to propel biotechnology and life sciences companies towards growing success.
The Bios Innovation Circle is a dynamic venture studio and strategic hub designed to catalyse the growth of start-ups and growing biotech and life sciences companies in a cost-effective and equity-sparing manner. By leveraging this powerful network, the Bios Innovation Circle offers tailored solutions including an extensive network of investors and partners eager to support promising ventures from concept to commercialisation.
The Bios Innovation Circle is aimed at empowering the success of Biotech and Life Sciences Companies, Investors, Pharmaceutical Companies, Clinical Research Organisations and other Innovative Solution Providers to accelerate development and bring life-saving treatments to the market faster.
The Bios Innovation Circle supports biotech and life science companies through access to funding to support growth. Its extensive network of investors offers funding from $1m-100m across therapy areas and stages, plus access to a comprehensive suite of tailored solutions such as Asset Optimisation, Due Diligence Validation, CMC, Regulatory, Clinical Studies, Trial Feasibility, Market analysis and others.
Benefitting from mentorship of industry veterans, biotech and life science member companies can attract funding, forge strategic alliances and maximise reach, whilst mitigating risk and better navigating complex challenges through invaluable strategic direction.
Investors gain access to a curated network of high-growth potential start-ups and emerging companies, maximising investment returns and identifying promising ventures.
Pharmaceutical companies stay ahead of the curve by identifying promising licensing and development opportunities to boost their pipeline and fuel their future growth.
Clinical Research Organisations (CROs) and innovative solution providers can expand their business development by engaging early and connecting with a dynamic ecosystem of innovative companies.
Speaking on the launch, Zizi Imatorbhebhe, CEO and managing partner of Bios Health Group, explains: “The Bios Innovation Circle is shattering traditional models and disrupting the status quo. We’re building a collaborative powerhouse where visionary ideas converge with strategic expertise, fostering a holistic environment that accelerates progress and unlocks the true potential of life-changing therapies, bringing value to the stakeholders. A real revolution in life science development.”
About Bios Health Group
Bios Health Group is a comprehensive strategic partner for the life sciences industry. We offer a unique combination of expertise, resources and connections to empower companies at all stages of development to achieve breakthrough success. Through our innovative solutions and unparalleled network, we are dedicated to helping them address their pain points, accelerate the development of life-saving therapies and foster a thriving life sciences ecosystem. Visit: www.bioshealthgroup.com
